# Hillstream BioPharma (stock symbol: HILS) Logo in transparent PNG and SVG formats

## Hillstream BioPharma Logo large

### Hillstream BioPharma Logo large Download PNG (57.85 KB)

![Hillstream BioPharma Logo large Download PNG (57.85 KB)](/img/orig/HILS_BIG-0bdcb9a5.png)

### Hillstream BioPharma Logo large Download SVG (10.33 KB)

![Hillstream BioPharma Logo large Download SVG (10.33 KB)](/img/orig/HILS_BIG-2e319fec.svg)

## Hillstream BioPharma Logo icon format

### Hillstream BioPharma Logo icon format Download PNG (33.96 KB)

![Hillstream BioPharma Logo icon format Download PNG (33.96 KB)](/img/orig/HILS-02d6bb15.png)

### Hillstream BioPharma Logo icon format Download SVG (2.4 KB)

![Hillstream BioPharma Logo icon format Download SVG (2.4 KB)](/img/orig/HILS-d60d84b9.svg)

## About Hillstream BioPharma

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a targeted bifunctional inhibitory compound in Quatramer with single digit nanomolar IC50 against PI3K-delta and HDAC6, which is also known to downregulate; and HSB-114, an immunotherapeutic agent, which uses its Quatramer technology to deliver tumor necrosis factor-alpha gene into cancer cells. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.

1. Website domain: hillstreambio.com
2. Employees: 1
3. Marketcap: $5.08 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
